Vesugen
A short bioregulator peptide studied mostly in Russian laboratory research related to blood vessels.
- Type
- Short peptide (bioregulator)
- Research area
- Bioregulator peptides
- Research stage
- Laboratory research; limited clinical use outside the U.S.
- FDA status
- Not an FDA-approved medicine
About Vesugen
A short bioregulator peptide studied mostly in Russian laboratory research related to blood vessels.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Related compounds
VilonVilon
A dipeptide bioregulator studied mostly in Russian laboratory research related to the immune system.
ThymogenThymogen
A dipeptide studied mostly in Russian research related to the immune system.
ThymalinThymalin
A thymus-derived peptide preparation used in Russia; not approved in the United States.